Home » Newsletters » BioWorld Science

BioWorld Science

July 18, 2011

View Archived Issues

New modulators of metabotropic glutamate mGlu5 receptor presented

Pilot study provides proof of principle for ALX-0081 in percutaneous coronary intervention

Phase II data support use of ThromboView in SPECT for diagnosis of acute pulmonary embolism

Hydrogen sulfide donor GYY-4137 exhibits potent preclinical antitumor activity

Ajinomoto set for Japanese launch of Azuloxa tablets for gastric ulcers

Researchers describe pharmacological profile of AM-211

Novel integrin alpha-V/beta-6 ligands patented by GE Healthcare

New diagnostic glutamate carboxypeptidase 2 inhibitors synthesized

InterMune presents new HCV replication inhibitors

Novo Nordisk discloses novel glucagon GLP-1 receptor agonists

New gap junction hemichannel blocker prevents disease progression in murine models of ALS and AD

New PI3K-delta inhibitors prepared by Incyte

Nycomed patents new inhibitors of phosphodiesterase 4B and/or phosphodiesterase 5A

BioFocus and Michael J. Fox Foundation collaborate for Parkinson's disease

BerGenBio prepares for clinical studies of lead oncology candidate BGB-324

Laboratoires Takeda withdraws pioglitazone-containing products from French market

FDA approves highest dose strength of Zenpep to date

Leo Pharma and The Scripps Research Institute enter collaboration for treatment of skin diseases

Topline phase III data reported on fixed-dose levomilnacipran in MDD

Almirall launches Sativex in Denmark for spasticity due to MS

NeoStem signs definitive merger agreement to acquire Amorcyte

Amgen gains European marketing approval for Xgeva

QrxPharma files MoxDuo NDA in U.S. for severe pain

FDA accepts for review MedImmune's sBLA for quadrivalent influenza vaccine Q/LAIV

Cell Biosciences becomes ProteinSimple

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 30, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...